Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JGA8 | ISIN: KYG2114L1059 | Ticker-Symbol:
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA NT PHARMA GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
CHINA NT PHARMA GROUP CO LTD 5-Tage-Chart

Aktuelle News zur CHINA NT PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CHINA NT PHARMA Aktie jetzt für 0€ handeln
MoNT PHARMA (01011): DELAY IN DESPATCH OF CIRCULAR-
MoNT PHARMA (01011): TERMS OF REFERENCE OF NOMINATION COMMITTEE1
MoNT PHARMA (01011): CHANGE IN COMPOSITION OF BOARD COMMITTEE-
MoNT PHARMA (01011): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION1
MoNT PHARMA (01011): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 30 JUNE 2025-
19.05.NT PHARMA (01011): CHANGE OF CHIEF EXECUTIVE OFFICER1
09.05.NT PHARMA (01011): VOLUNTARY ANNOUNCEMENT1
30.04.NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER-
30.04.NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDER-
30.04.NT PHARMA (01011): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING-
30.04.NT PHARMA (01011): NOTICE OF ANNUAL GENERAL MEETING1
30.04.NT PHARMA (01011): PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE ...-
30.04.NT PHARMA (01011): ANNUAL REPORT 2024-
29.04.NT PHARMA (01011): CLARIFICATION ANNOUNCEMENT - MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING ...1
28.04.NT PHARMA (01011): MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE OF CONSIDERATION ...-
31.03.NT PHARMA (01011): ANNOUNCEMENT OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024-
20.03.NT PHARMA (01011): CLARIFICATION ANNOUNCEMENT IN RELATION TO DATE OF BOARD MEETING-
19.03.NT PHARMA (01011): DATE OF BOARD MEETING1
21.02.NT PHARMA (01011): NEXT DAY DISCLOSURE RETURN1
21.02.NT PHARMA (01011): COMPLETION OF CONNECTED TRANSACTION IN RELATION TO LOAN CAPITALIZATION INVOLVING SUBSCRIPTION OF SHARES UNDER SPECIFIC MANDATE-
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1